Soft Capsules Drugs Market

Softgelcapsulesare typically a gelatin-based shell, containing a liquid. They can be used as a dosage form for a variety ofmedicines, including complementarymedicines, such as vitamins. In some cases, thesemedicinesmay have directions for use that say that they can or should be chewed.

Soft Capsules Drugs Market contains market size and forecasts of Soft Capsules Drugs in Global, including the following market information:

• Global Soft Capsules Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Soft Capsules Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

• The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
• Liquid Core Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
• The global key manufacturers of Soft Capsules Drugs include GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, Novartis, Teva, Chiesi and Sumitomo Dainippon, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
• surveyed the Soft Capsules Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Soft Capsules Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Soft Capsules Drugs Market Segment Percentages, by Type, 2021 (%)

• Liquid Core Drugs
• Semi-solid Core Drugs

Global Soft Capsules Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Soft Capsules Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Retail Pharmacy

Global Soft Capsules Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Soft Capsules Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Soft Capsules Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Soft Capsules Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GSK
• AstraZeneca
• Boehringer Ingelheim
• Vertex
• Roche
• Novartis
• Teva
• Chiesi
• Sumitomo Dainippon
• Merck
• Atrium Innovations
• Abbott
• Blackmores
• The Clorox Company
• Nature Made
• By-health
• A&Z Pharmaceutical